Pharma Strategies (Private) Limited
to ensure you remain relevant in competitive markets. We support clients in the pharmaceutical and medical products industries. Our focus is on Product Development Strategies, Business Development, Access to New Markets, Clinical Research Development, Corporate Strategy, Innovation Management, CME and Marketing. We provide methodologically sophisticated yet practical advice that helps clients significantly improve their companies’ returns on based on the solutions we provide. We make sure we generate client buy-in to the solutions that we develop.
We are committed to pushing ourselves to think beyond our projects to better understand and prepare for an evolving industry. Our clients choose us to advise them on their most important corporate, business unit, and product strategic decisions, and ask for our help in solving their most difficult issues.
From the Founder's Desk...
In recent years, pharmaceutical companies have been faced with drastically changing market conditions. The demand side is dominated by rapidly changing legislation, an increasing number of regulations and tougher requirements placed on companies by regulatory authorities as well as increasing pricing pressure...Mr. Pias Musiza Founding Director
Pias is a Founding Director of...
Memory Musiza is a Director at...
Tawanda Mtendi is the company's Administrator...
We have a great support team...
Novartis data show Cosentyx® treatment results in rapid and sustained resolution of signs and symptoms of psoriatic arthritis in patients with and without enthesitis
New two-year data compare the effects of Cosentyx (secukinumab) treatment in psoriatic arthritis patients with and without enthesitis, a manifestation described in 30-50% of patients  Results from a pooled analysis of...More
Novartis real-world evidence confirms high efficacy, long-term response and favorable safety profile of Cosentyx® in clinical practice
Data from five real-world evidence (RWE) and observational studies being conducted in North America, Latin America and Europe provide extensive cumulative insights for Cosentyx (secukinumab) clinical practice among more than 13,000 patients...More
For American chef Christine Hà, the life-changing experience of losing sight as a teenager – due to a central nervous system disorder called neuromyelitis optica – came with an unexpected twist. “Vision...More